Pyxis Oncology, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveOct 5 →InsidersNo open-market buys or sales.→HoldersGordonMD Global Investments 15.8%Pfizer 11.1%Laurion 7.7%→PeersClosest companies: IDYA, JANX, CTMX→
From the filings
Figures
- Revenue
- $13.9Mlast 12 months
- Net income
- −$88.7Mlast 12 months
- Operating cash flow
- −$67.0Mlast 12 months
- Cash and equivalents
- $18.9Mat the last balance sheet
- Shares outstanding
- 63.4M shareson issue